法国胰腺手术的理论与实践:全国性胰腺切除术量与短期结局分析
该研究基于法国2007至2012年医疗数据库,纳入22366例择期胰腺切除术成人患者,90天死亡率为8.1%。样条模型识别出年手术量25例和65例两个界值,与年手术量>65例的中心相比,≤25例和26至65例中心的校正死亡OR分别为1.865和1.234。研究认为胰腺手术集中化理论合理但当前难以实现。
要点
- 年胰腺切除术量≤25例的中心死亡风险显著高于>65例的中心(校正OR 1.865)。
- 胰十二指肠切除术年量16例和40例为独立死亡预测界值(校正OR 1.979和1.333)。
- 远端胰腺切除术年量13例和25例界值非独立预测因素(模型AUC 0.778)。
核心结论
- 胰腺手术集中化在理论上有依据,但当前尚不可行。
- 随着胰腺癌发病率增加,亟需改进外科医生培训并发展中等量及高量中心。
研究设计与样本
- 基于法国医疗数据库的全国性回顾性队列研究,筛选2007至2012年所有择期胰腺切除术成人患者。
- 共纳入22366例胰腺切除术患者,主要终点为90天死亡率。
- 采用样条模型识别影响死亡率的年手术量界值,并用逻辑回归评估其独立性及模型准确性。
主要发现
- 总体90天死亡率为8.1%。
- 每年实施≤25例、26至65例、>65例胰腺切除术的机构平均数量分别为456、20、9家,对应患者比例分别为56.6%、19.9%、23.3%。
- 胰十二指肠切除术(12670例,死亡率9.2%)有2个界值(每年16例和40例),均为独立死亡预测因素(校正OR 1.979和1.333)。
- 远端胰腺切除术(7085例,死亡率6.2%)有2个界值(每年13例和25例),但均非独立结局预测因素(模型AUC 0.778)。
临床怎么用
- 胰腺切除术应优先集中在年手术量>65例的中心以降低90天死亡风险。
- 年手术量≤25例的中心死亡风险显著升高,应作为集中化政策的首要调整对象。
- 胰十二指肠切除术对年手术量依赖更明显,年量≤16例时死亡风险尤其升高。
局限性
- 原文未报告局限性相关内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Measure the caseload of pancreatectomies that influences their short-term outcome, at a national level, and assess the applicability of a centralization policy. BACKGROUND: There is agreement that pancreatectomies should be centralized. However, previous studies have failed to accurately define a "high-volume" center. METHODS: French healthcare databases were screened to identify all adult patients who had elective pancreatectomies between 2007 and 2012. The patients' age, comorbidities, indication, and extent of surgery, and also the hospital administrative-type and location were retrieved. The annual-caseload of pancreatectomy was calculated for each hospital facility. The primary endpoint was 90-day mortality. Spline modeling was used to identify the different annual-caseload that influenced mortality. Logistic regressions were performed to assess if their influence was independent of confounders, and the accuracy of the model calculated. RESULTS: Overall, 22,366 patients underwent a pancreatectomy and the mortality was 8.1%. Two cut-offs were identified (25 and 65 per year): compared with centers performing >65 resections per year, the adjusted OR of mortality was 1.865 (1.529-2.276) in centers performing ≤25 resections per year and 1.234 (1.031-1.478) in those performing 26 to 65 resections per year. The average number of facilities performing ≤25, 26 to 65, and >65 pancreatectomies per year was 456, 20, and 9, respectively. The percentage of patients operated in these facilities was 56.6%, 19.9%, and 23.3%, respectively.For pancreaticoduodenectomies (12,670 patients; mortality 9.2%), there were 2 cut-offs (16 and 40 pancreaticoduodenectomies per year), and both were independent predictors of mortality (adjusted OR of 1.979 and 1.333). For distal pancreatectomies (7085 patients; 6.2% mortality), there were 2 cut-offs (13 and 25 distal pancreatectomies per year), but neither was an independent predictor of outcome (area under the receiver-operating characteristic curve of the model = 0.778). CONCLUSIONS: Centralization of pancreatic surgery is theoretically justified, but currently unrealizable. As the incidence of pancreatic cancer increases, there is an urgent need to improve the training of surgeons and develop both intermediate and high-volume centers.
引用
- Farges O, Bendersky N, Truant S, et al. The Theory and Practice of Pancreatic Surgery in France. Ann Surg. 2017. PMID: 28885506. doi:10.1097/SLA.0000000000002399
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。